Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers

Neurobiology of Aging

Volumn 33, Issue 6, 2012, Pages 1054-1056

  Lau, Simon ^a,b   Bates, Kristyn Alissa ^b,c,d   Sohrabi, Hamid R ^c,d   Rodrigues, Mark ^b,c,d   Martins, Georgia ^b,c,d   Dhaliwal, Satvinder S ^e   Taddei, Kevin ^b,c,d   Laws, Simon M ^b,c   Martins, Ian J ^b,c,d   Mastaglia, Francis L ^d   Foster, Jonathan K ^b,c   Phillips, Jacqueline K ^a,f   Martins, Ralph N ^b,c,d  

^a MURDOCH UNIVERSITY   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

^c HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; COHORT ANALYSIS; FOLLOW UP; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEREDITY; HOMOZYGOSITY; HUMAN; IL 1A GENE; IL 1B GENE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TNF GENE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MEMORY; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859506686     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.09.003     Document Type: Article

References (8)

1. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
2. Du Y., Dodel R.C., Eastwood B.J., Bales K.R., Gao F., Lohmuller F., Muller U., Kurz A., Zimmer R., Evans R.M., Hake A., Gasser T., Oertel W.H., Griffin W.S., Paul S.M., Farlow M.R. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 2000, 55:480-483.
3. Jonker C., Geerlings M.I., Schmand B. Are memory complaints predictive for dementia?. A review of clinical and population-based studies. Int. J. Geriatr. Psychiatry 2000, 15:983-991.
4. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol 1997, 34:391-399.
5. Laws S.M., Perneczky R., Wagenpfeil S., Muller U., Forstl H., Martins R.N., Kurz A., Riemenschneider M. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum. Mutat 2005, 26:29-35.
6. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A., Sciacca F.L., Veglia F., Annoni G., Bonafe M., Olivieri F., Franceschi C., Grimaldi L.M. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol 2000, 48:388-391.
7. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol 2000, 47:365-368.
8. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., Nilsson L.N. Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. J. Biol. Chem 1999, 274:6421-6431.